TagsOfirnoflast

Tag: Ofirnoflast

Healthcare

Halia Therapeutics to Present Final Phase 2 Ofirnoflast Data in Lower-Risk MDS at EHA2026 and Announces Appointment of Han Myint, MD, FACP, as Chief...

Ravindra Soni - May 12, 2026 0

Healthcare

Halia Therapeutics Announces Positive Phase 2a Data for Ofirnoflast in Lower-Risk MDS at ASH 2025

Ravindra Soni - December 8, 2025 0

Healthcare

Halia Therapeutics to Present Groundbreaking Data on Novel Allosteric NEK7 Inhibitor Ofirnoflast at the 2025 American Society of Hematology Annual Meeting

Ravindra Soni - November 10, 2025 0

Healthcare

Ofirnoflast (HT-6184) Receives Orphan Drug Designation from U.S. FDA for Myelodysplastic Syndromes

Ravindra Soni - October 23, 2025 0

Most Read

INOX India Q2 FY27 revenue rises 26.6% to ₹467 crore, order backlog hits record

November 3, 2026

Doodhvale Farms wins Emerging D2C Dairy Protein Brand at The India Collective

November 3, 2026

NSN Mohan elected first Indian SKÅL International World President for 2027

November 3, 2026

Wintermar Offshore Q3 profit surges 67.6% on higher vessel margins

November 3, 2026